These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 33650207)

  • 21. Mineralocorticoid Antagonists in the Treatment of Central Serous Chorioretinopathy: A Comparative Analysis.
    Kapoor KG; Wagner AL
    Ophthalmic Res; 2016; 56(1):17-22. PubMed ID: 26982318
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Choroidal Vascular Flow Area in Central Serous Chorioretinopathy Using Swept-Source Optical Coherence Tomography Angiography.
    Nicolò M; Rosa R; Musetti D; Musolino M; Saccheggiani M; Traverso CE
    Invest Ophthalmol Vis Sci; 2017 Apr; 58(4):2002-2010. PubMed ID: 28384721
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictive Factors of Response to Mineralocorticoid Receptor Antagonists in Nonresolving Central Serous Chorioretinopathy.
    Bousquet E; Dhundass M; Lejoyeux R; Shinojima A; Krivosic V; Mrejen S; Gaudric A; Tadayoni R
    Am J Ophthalmol; 2019 Feb; 198():80-87. PubMed ID: 30308202
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictors of Outcome During Eplerenone Therapy in Chronic Central Serous Chorioretinopathy:A Prospective, Open-Label Pilot Clinical Study.
    Rajesh B; Agrawal H; Peguda HK; Chhablani J
    Ophthalmic Surg Lasers Imaging Retina; 2018 Jul; 49(7):479-486. PubMed ID: 30021034
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of subfoveal choroidal blood flow in age-related macular degeneration.
    Pournaras CJ; Logean E; Riva CE; Petrig BL; Chamot SR; Coscas G; Soubrane G
    Invest Ophthalmol Vis Sci; 2006 Apr; 47(4):1581-6. PubMed ID: 16565395
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Abnormal choroidal flow on optical coherence tomography angiography in central serous chorioretinopathy.
    Seo EJ; Um T; Yoon YH
    Clin Exp Ophthalmol; 2019 May; 47(4):505-512. PubMed ID: 30515936
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The use of mineralocorticoid receptor antagonists in chronic central serous chorioretinopathy.
    Pociej-Marciak W; Karska-Basta I; Ozog-Baran J; Kubicka-Trzaska A; Filemonowicz-Skoczek A; Romanowska-Dixon B
    Klin Oczna; 2016 Aug; 118(1):48-54. PubMed ID: 29715409
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Choroidal thickness measurements during central serous chorioretinopathy treatment.
    Brandl C; Helbig H; Gamulescu MA
    Int Ophthalmol; 2014 Feb; 34(1):7-13. PubMed ID: 23572440
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vascular and structural alterations of the choroid evaluated by optical coherence tomography angiography and optical coherence tomography after half-fluence photodynamic therapy in chronic central serous chorioretinopathy.
    Demirel S; Özcan G; Yanık Ö; Batıoğlu F; Özmert E
    Graefes Arch Clin Exp Ophthalmol; 2019 May; 257(5):905-912. PubMed ID: 30617579
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impairment of visual acuity and retinal morphology following resolved chronic central serous chorioretinopathy.
    Gawęcki M; Jaszczuk-Maciejewska A; Jurska-Jaśko A; Kneba M; Grzybowski A
    BMC Ophthalmol; 2019 Jul; 19(1):160. PubMed ID: 31345183
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of nifedipine on choroidal blood flow regulation during isometric exercise.
    Schmidl D; Prinz A; Kolodjaschna J; Polska E; Luksch A; Fuchsjager-Mayrl G; Garhofer G; Schmetterer L
    Invest Ophthalmol Vis Sci; 2012 Jan; 53(1):374-8. PubMed ID: 22199246
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Choroidal hemodynamic changes during isometric exercise in patients with inactive central serous chorioretinopathy.
    Tittl M; Maar N; Polska E; Weigert G; Stur M; Schmetterer L
    Invest Ophthalmol Vis Sci; 2005 Dec; 46(12):4717-21. PubMed ID: 16303970
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mineralocorticoid antagonists in the treatment of central serous chorioetinopathy: Review of the pre-clinical and clinical evidence.
    Bousquet E; Zhao M; Daruich A; Behar-Cohen F
    Exp Eye Res; 2019 Oct; 187():107754. PubMed ID: 31401003
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Minoxidil induced central serous Chorioretinopathy treated with oral Eplerenone - a case report.
    Venkatesh R; Pereira A; Jain K; Yadav NK
    BMC Ophthalmol; 2020 Jun; 20(1):219. PubMed ID: 32503484
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Eplerenone for the treatment of chronic central serous chorioretinopathy: 3-year clinical experience.
    Petkovsek DS; Cherfan DG; Conti FF; Hom GL; Ehlers JP; Babiuch AS; Rachitskaya AV; Kaiser PK; Schachat AP; Srivastava SK; Sharma S; Singh RP
    Br J Ophthalmol; 2020 Feb; 104(2):182-187. PubMed ID: 31079056
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mineralocorticoid receptor antagonism in the treatment of chronic central serous chorioretinopathy: a pilot study.
    Bousquet E; Beydoun T; Zhao M; Hassan L; Offret O; Behar-Cohen F
    Retina; 2013; 33(10):2096-102. PubMed ID: 23719402
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Change in choroidal vascularity in acute central serous chorioretinopathy.
    Rasheed MA; Goud A; Mohamed A; Vupparaboina KK; Chhablani J
    Indian J Ophthalmol; 2018 Apr; 66(4):530-534. PubMed ID: 29582814
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mineralocorticoid Receptor Antagonists in Central Serous Chorioretinopathy: A Meta-Analysis of Randomized Controlled Trials.
    Wang SK; Sun P; Tandias RM; Seto BK; Arroyo JG
    Ophthalmol Retina; 2019 Feb; 3(2):154-160. PubMed ID: 31014765
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Systemic Mineralocorticoid Antagonists in the Treatment of Central Serous Chorioretinopathy.
    Yang D; Eliott D
    Semin Ophthalmol; 2017; 32(1):36-42. PubMed ID: 27929707
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Choroidal modifications assessed by means of choroidal vascularity index after oral eplerenone treatment in chronic central serous chorioretinopathy.
    Toto L; Ruggeri ML; Evangelista F; Viggiano P; D'Aloisio R; De Nicola C; Falconio G; Di Nicola M; Porreca A; Mastropasqua R
    Eye (Lond); 2023 Apr; 37(6):1214-1218. PubMed ID: 35590104
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.